Delivery Order 75N91019D00032-75N91019F00129
Award Date 8/31/19
Potential Completion Date 8/30/20
Potential Value $2.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $274,036 fixed-price task order awarded to the New York Genome Center, Inc. (Nygc) by the National Cancer Institute (NCI) under the NCI Genomic Characterization Centers master IDIQ contract. The purpose is to provide DNA methylation arrays to support new studies by the Cancer Genomics Program over a 3-year period of performance from September 2020 to September 2023. This task order is fully funded and non-severable. Nygc is a nonprofit academic research institution that provides...
- This is a Firm Fixed Price delivery order awarded by the National Cancer Institute (NCI) to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution, for a Single Cell Sequencing Task Order under the NCI Genomic Characterization Centers master IDIQ contract. The period of performance is from September 16, 2019 to September 15, 2022, with a ceiling value of $190,664.68. The order is in support of NCI's Center for Cancer Genomics program and does not have a set-aside...
- <p>The National Cancer Institute issued a $2,675 delivery order to Genewiz, LLC on August 31, 2019, under the NCI Genomic Characterization Centers IDIQ for genomic characterization services supporting the Center for Cancer Genomics.</p> <p>The NCI Genomic Characterization Centers IDIQ provides cancer genomics capabilities to the National Cancer Institute. Place of performance is South Plainfield, NJ. The order was firm fixed price with an ultimate completion date of August 30, 2020.</p>
- The National Cancer Institute awarded a delivery order valued at $2.68 million to The Broad Institute, Inc. for DNA whole genome sequencing services supporting new Cancer Genomics Consortium studies. The contract, which commenced September 1, 2020 and was initially scheduled to conclude August 31, 2023, operates under the NCI Genomic Characterization Centers master indefinite delivery contract as a parent vehicle. Performance will be conducted in Cambridge, Massachusetts, with firm fixed-price...
- The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...
- This is a $13,468,050.00 definitive, firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract is for special studies and analysis services, with no set-aside designation. NYGC has a $500 million indefinite delivery, indefinite quantity (IDIQ) contract with NHLBI for the Trans-Omics for Precision Medicine (TOPMed) program to provide...
- This federal contract award of $89,299.99 to the New York Genome Center, Inc. (Nygc) was issued by the Veterans Integrated Service Network 2 (a component of the U.S. Department of Veterans Affairs) to provide genome sequencing services in support of research. The contract is a firm fixed-price purchase order, with an ultimate completion date of December 31, 2021. Nygc is a nonprofit academic research institution that specializes in advanced genomic sequencing, analysis, and computational...
- This is a delivery order award to the New York Genome Center, Inc. (doing business as Nygc), a nonprofit academic research institution, under the Centralized Omic REsource for TOPMed (CORE) Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Heart, Lung, and Blood Institute (NHLBI). The order, valued at $5,906,039.00, is for the fifth year of the Centralized Omics Resource (CORE) project, which provides centralized omics data analysis and management services to support...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $3 million firm fixed price purchase order to 10X Genomics, Inc. for genomics products and services. As the prime contractor, 10X Genomics will deliver its genome sequencing platforms and assays to support the agency's cancer research efforts from its Pleasanton, California location through the end of 2023. No subcontractors or set aside designations were indicated. This award draws on...
- This is a firm fixed-price delivery order awarded by the National Institute of Mental Health (NIMH) to the New York Genome Center, Inc. (NYGC) for Task Area 1: Manual of Operations under the Brain Initiative Cell Atlas Network (BICAN) Sequencing Core contracts. The contract has a ceiling value of $38,000.00 and an ultimate completion date of May 13, 2025. NYGC, a non-profit academic research institution, will provide specialized genomic sequencing and analysis services to support the BRAIN...